Stuart Mannering received his PhD from the University of Otago, New Zealand, for work on human T-cell responses to tumour antigens in chronic myeloid leukemia. He undertook postdoctoral training in Australia at the University of Melbourne. In 2001 he started working on type 1 diabetes at the Walter and Eliza Hall Institute (WEHI). His work has focused on human T-cell responses to beta-cell antigens, specifically developing new assays to detect beta-cell antigen specific T-cell responses in the PBMC and defining new epitopes, particularly those formed by posttranslational modification. In 2008 he established a group at St. Vincent’s Institute (SVI) in Melbourne, Australia. At SVI his lab is working on the analysis of T-cell clones from the islets of deceased organ donors who suffered from type 1 diabetes.
Abstracts this author is presenting: